Immune-Related Fulminant Myocarditis Revealed Using Myocardial Histopathology at Autopsy in the Treatment of Advanced Renal Cell Carcinoma: A Case Report
Delay in the initiation of treatment is considered a risk factor for poor prognosis, and the administration of high-dose steroids within 24 h of onset contributes to a better outcome. Herein, we discuss the pathology, diagnosis, and treatment of immune checkpoint inhibitor-associated myocarditis.
Authors
- Rie Sakagami
- Hiromichi Katayama (ORCID: https://orcid.org/0000-0001-8339-5164)
- Tomonori Sato (ORCID: https://orcid.org/0000-0001-5659-6809)
- Satoko Sato
- Naoki Kawamorita (ORCID: https://orcid.org/0000-0001-6175-3063)
- Yohei Satake (ORCID: https://orcid.org/0000-0003-3961-1004)
- Yuka Hayashi (ORCID: https://orcid.org/0000-0001-8970-1978)
- Shinichi Yamashita (ORCID: https://orcid.org/0000-0003-3092-7715)
- Takuma Sato (ORCID: https://orcid.org/0000-0002-2213-3117)
- Takuro Goto (ORCID: https://orcid.org/0000-0002-1794-5049)
- Akihiro Itô (ORCID: https://orcid.org/0000-0002-8698-0032)
- Yoshihide Kawasaki (ORCID: https://orcid.org/0000-0001-6425-3574)
- Hiroyuki Takahama (ORCID: https://orcid.org/0000-0002-4868-0901)
Institutions
- Tohoku University (JP)
- Tohoku University Hospital (JP)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1159/000546288
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00